Overview

Temozolomide in Treating Women With Advanced Breast Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating women who have advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
The Christie NHS Foundation Trust
Treatments:
Temozolomide